NCM
MRNA icon

NCM Capital Management’s Moderna MRNA Stock Holding History

NCM Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,437
Closed -$221K – 156
2023
Q1 		$221K Hold
1,437
– – 0.17% 133
2022
Q4 		$258K Buy
+1,437
New +$235K 0.17% 146
2022
Q2 		– Sell
-1,337
Closed -$230K – 185
2022
Q1 		$230K Sell
1,337
-82
-6% -$13.8K 0.14% 168
2021
Q4 		$360K Buy
+1,419
New +$415K 0.32% 98

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NCM Capital Management's MRNA Position: Q2 2023 in Review

NCM Capital Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,437 shares — an estimated $221K sold.

NCM Capital Management first reported a position in MRNA in Q4 2021 and held it in 4 quarters. The position peaked at $360K in Q4 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • NCM Capital Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • NCM Capital Management sold 1,437 Moderna shares in Q2 2023, an estimated $221K.
  • NCM Capital Management first reported a position in Moderna in Q4 2021 and held it in 4 quarters.
  • NCM Capital Management's Moderna position peaked at $360K in Q4 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on NCM Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.